Display options
Cite
Polunina AG, Bryun EA. Neuropsychological Functions of μ- and δ-Opioid Systems. ISRN Addict. 2013;2013:674534doi: 10.1155/2013/674534.
Polunina, A. G., & Bryun, E. A. (2013). Neuropsychological Functions of μ- and δ-Opioid Systems. ISRN Addiction, 2013674534. https://doi.org/10.1155/2013/674534
Polunina, Anna G, and Bryun, Evgeny A. "Neuropsychological Functions of μ- and δ-Opioid Systems." ISRN Addiction vol. 2013 (2013): 674534. doi: https://doi.org/10.1155/2013/674534
Polunina AG, Bryun EA. Neuropsychological Functions of μ- and δ-Opioid Systems. ISRN Addict. 2013 Dec 26;2013:674534. doi: 10.1155/2013/674534. eCollection 2013. PMID: 25938117; PMCID: PMC4392981.
Copy Download .nbib Format: NLM
Share it on

ISRN Addict. 2013 Dec 26;2013:674534. doi: 10.1155/2013/674534. eCollection 2013.

Neuropsychological Functions of μ- and δ-Opioid Systems.

ISRN Addiction

Anna G Polunina, Evgeny A Bryun

Affiliations

  1. Moscow Research and Practical Center for Narcology, Department of Healthcare, 37/1 Lyublinskaya ul., Moscow 109390, Russia.

PMID: 25938117 PMCID: PMC4392981 DOI: 10.1155/2013/674534

Abstract

Brain opioid innervation is involved in many pathophysiological processes related to drug addiction. The main idea of the present review is that μ-/δ-opioid innervation is an intrinsic component of the motor/approach behavior network, which is activated synergetically with dopaminergic mesocorticolimbic network. Contribution of opioid innervation to the motor/approach behavior processing includes generation of positive emotions and inhibition of pain and stress reactions in order that the individual would be able to reach the vital goal. We cite the neuroanatomical data which showed that motor subcortical nuclei contain the most abundant opioid innervation and its activation is an obligatory component of positive emotions. In the majority of life situations, motor/approach behavior network concomitantly activates pain/stress control opioid network. Intensive cognitive activity induces activation of opioid innervation as well, and both enhancing and impairing effects of opioid agonists on cognitive functioning were demonstrated. Overall, the functioning of endogenous opioid networks may be summarized as following: NO physical/cognitive activity = NO positive emotions plus NO pain/stress control. We suppose that contemporary findings concerning neuropsychological functions of endogenous opioid system explain many controversial issues in neuropsychiatric conditions predisposing to drug addiction and neurological mechanisms of opioid addiction.

References

  1. Ann N Y Acad Sci. 2009 Mar;1156:198-210 - PubMed
  2. Proc Natl Acad Sci U S A. 2002 May 14;99(10 ):7084-9 - PubMed
  3. Arch Gen Psychiatry. 2006 Nov;63(11):1199-208 - PubMed
  4. Neuroscience. 2009 Jun 16;161(1):157-72 - PubMed
  5. Pain. 2007 Aug;130(3):208-15 - PubMed
  6. Synapse. 2002 Dec 15;46(4):271-9 - PubMed
  7. Neurology. 2010 Jul 13;75(2):129-36 - PubMed
  8. Alcohol Clin Exp Res. 2001 Apr;25(4):524-30 - PubMed
  9. J Neurophysiol. 2000 Dec;84(6):3072-7 - PubMed
  10. Pharmacol Rev. 2007 Mar;59(1):88-123 - PubMed
  11. Behav Brain Res. 2009 Jan 23;196(2):155-67 - PubMed
  12. Neuropsychopharmacology. 2000 Jun;22(6):595-607 - PubMed
  13. J Comp Neurol. 2006 Aug 20;497(6):910-27 - PubMed
  14. Eur J Neurosci. 2005 Jun;21(12):3301-9 - PubMed
  15. Neuron. 2002 Oct 10;36(2):229-40 - PubMed
  16. Pain. 2007 Jan;127(1-2):183-94 - PubMed
  17. Am J Psychiatry. 1998 Apr;155(4):470-3 - PubMed
  18. Neurobiol Aging. 2008 Feb;29(2):309-13 - PubMed
  19. J Biomed Sci. 2010 Apr 21;17:29 - PubMed
  20. Neuropsychopharmacology. 2010 Jan;35(1):4-26 - PubMed
  21. Soc Cogn. 2008 Oct 1;26(5):621-646 - PubMed
  22. Pain Med. 2013 May;14(5):667-75 - PubMed
  23. Neuropsychopharmacology. 2009 Sep;34(10):2329-43 - PubMed
  24. Neuropharmacology. 2013 Dec;75:78-85 - PubMed
  25. Curr Neuropharmacol. 2012 Sep;10(3):231-8 - PubMed
  26. Neuroimage. 2006 Jun;31(2):661-9 - PubMed
  27. J Neurosci. 2008 Oct 15;28(42):10509-16 - PubMed
  28. Drug Alcohol Depend. 2005 May 9;78(2):177-86 - PubMed
  29. Am J Psychiatry. 2010 Aug;167(8):925-33 - PubMed
  30. Psychol Bull. 2000 Nov;126(6):890-909 - PubMed
  31. J Neurosci. 2008 Dec 24;28(52):14007-17 - PubMed
  32. Dev Psychobiol. 2009 Jul;51(5):439-49 - PubMed
  33. Brain Res Brain Res Rev. 2001 Oct;36(2-3):129-38 - PubMed
  34. Curr Top Med Chem. 2004;4(1):1-17 - PubMed
  35. Annu Rev Psychol. 2003;54:25-53 - PubMed
  36. J Cereb Blood Flow Metab. 2008 Aug;28(8):1514-22 - PubMed
  37. J Affect Disord. 2010 Jul;124(1-2):134-40 - PubMed
  38. J Abnorm Psychol. 2010 Feb;119(1):115-25 - PubMed
  39. Physiol Rev. 2009 Oct;89(4):1379-412 - PubMed
  40. Br J Pharmacol. 2006 Jan;147 Suppl 1:S153-62 - PubMed
  41. J Neurosci. 2004 Apr 28;24(17 ):4105-12 - PubMed
  42. Ann N Y Acad Sci. 1999 Jun 29;877:176-201 - PubMed
  43. Pain. 2004 May;109(1-2):86-93 - PubMed
  44. Psychopharmacology (Berl). 1997 Jul;132(1):50-60 - PubMed
  45. Mol Pain. 2009 Jun 23;5:32 - PubMed
  46. J Neurosci. 1997 Nov 1;17(21):8596-612 - PubMed
  47. Exp Neurol. 1988 Aug;101(2):159-75 - PubMed
  48. Psychol Rev. 2010 Apr;117(2):623-36 - PubMed
  49. J Comp Neurol. 2007 Jan 20;500(3):530-41 - PubMed
  50. Trends Neurosci. 1988 Jul;11(7):308-14 - PubMed
  51. Arch Gen Psychiatry. 2003 Nov;60(11):1145-53 - PubMed
  52. Curr Biol. 2012 Jun 5;22(11):1019-22 - PubMed
  53. Neuropharmacology. 1994 Oct;33(10):1171-82 - PubMed
  54. J Cereb Blood Flow Metab. 2011 May;31(5):1321-33 - PubMed
  55. Neurobiol Learn Mem. 2011 Feb;95(2):206-20 - PubMed
  56. Front Neurosci. 2010 Sep 15;4:null - PubMed
  57. Neuroimage. 2010 Jan 1;49(1):731-7 - PubMed
  58. Cereb Cortex. 2007 Jan;17(1):238-49 - PubMed
  59. Neurobiol Learn Mem. 2008 Sep;90(2):434-42 - PubMed
  60. J Neurosci. 2002 Dec 1;22(23 ):10192-200 - PubMed
  61. J Biol Chem. 2011 Sep 9;286(36):31731-41 - PubMed
  62. Pharmacol Rev. 1999 Jun;51(2):341-96 - PubMed
  63. Physiol Behav. 2009 May 25;97(2):205-12 - PubMed
  64. J Neurosci. 2008 Jul 9;28(28):7184-92 - PubMed
  65. J Neurol Sci. 2009 Apr 15;279(1-2):62-5 - PubMed
  66. J Neurosci. 2012 Mar 28;32(13):4540-52 - PubMed
  67. Biol Psychol. 2007 Jan;74(1):34-8 - PubMed
  68. J Neurosci. 2007 Feb 14;27(7):1594-605 - PubMed
  69. Trends Neurosci. 2013 Mar;36(3):195-206 - PubMed
  70. Anesth Analg. 2006 Jul;103(1):208-16, table of contents - PubMed
  71. Proc Natl Acad Sci U S A. 1998 May 12;95(10):5807-11 - PubMed
  72. Psychopharmacology (Berl). 2010 Dec;212(4):585-95 - PubMed
  73. Anesth Analg. 2003 Nov;97(5):1464-8 - PubMed
  74. Drug Alcohol Depend. 1998 Dec 1;53(1):79-86 - PubMed
  75. J Neurosci. 1999 Oct 15;19(20):9029-38 - PubMed
  76. Drug Alcohol Depend. 2003 Jul 20;71(1):65-75 - PubMed
  77. Neuroimage. 2006 Apr 15;30(3):692-9 - PubMed
  78. Am J Psychiatry. 2010 May;167(5):565-73 - PubMed
  79. Pain. 2008 Oct 15;139(2):406-15 - PubMed
  80. Trends Cogn Sci. 2009 Nov;13(11):479-87 - PubMed
  81. Neurology. 2002 Sep 10;59(5):724-8 - PubMed
  82. Endocrinology. 2010 Oct;151(10):4756-64 - PubMed
  83. Zh Nevrol Psikhiatr Im S S Korsakova. 1998;98(6):19-22 - PubMed
  84. Br J Rheumatol. 1994 Oct;33(10):909-16 - PubMed
  85. Br J Pharmacol. 2012 Aug;166(7):1993-2014 - PubMed
  86. Neuroscience. 1987 Feb;20(2):671-86 - PubMed
  87. Neuropsychopharmacology. 2010 Jan;35(1):27-47 - PubMed
  88. J Affect Disord. 2010 Sep;125(1-3):128-33 - PubMed
  89. Clin J Pain. 2012 Jul;28(6):542-55 - PubMed
  90. J Neurosci. 2009 May 20;29(20):6500-13 - PubMed
  91. Zh Nevrol Psikhiatr Im S S Korsakova. 2003;103(2):9-15 - PubMed
  92. Neuropsychologia. 1988;26(3):491-4 - PubMed
  93. J Neurosci. 2002 Jun 1;22(11):4709-19 - PubMed
  94. Curr Biol. 2012 Oct 23;22(20):1918-24 - PubMed
  95. Eur J Pharmacol. 2011 Jan 15;650(2-3):563-7 - PubMed
  96. Sleep Med. 2011 May;12(5):440-4 - PubMed
  97. Exp Neurol. 2012 Mar;234(1):112-26 - PubMed
  98. Brain Res Bull. 2010 Oct 30;83(5):278-83 - PubMed
  99. Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(1):102-9 - PubMed
  100. Addict Behav. 2013 Mar;38(3):1669-71 - PubMed
  101. Exp Neurol. 2011 Jan;227(1):149-58 - PubMed
  102. J Pharmacol Exp Ther. 2001 Dec;299(3):840-8 - PubMed
  103. J Integr Neurosci. 2012 Mar;11(1):117-22 - PubMed
  104. Neuroimage. 2008 Jan 1;39(1):538-47 - PubMed
  105. Science. 2007 Jan 26;315(5811):515-8 - PubMed
  106. J Neurosci. 1999 Aug 15;19(16):7175-81 - PubMed
  107. Brain Res. 1999 Mar 13;821(2):350-5 - PubMed
  108. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):225-30 - PubMed
  109. Brain Res. 2010 Feb 16;1314:56-73 - PubMed
  110. Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7579-84 - PubMed
  111. Neuron. 2004 Sep 30;44(1):161-79 - PubMed
  112. Dev Cogn Neurosci. 2012 Jan;2(1):103-9 - PubMed
  113. Neuropsychopharmacology. 2011 Oct;36(11):2200-10 - PubMed
  114. Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91 - PubMed
  115. J Pers Soc Psychol. 1988 Sep;55(3):479-88 - PubMed
  116. Exp Neurol. 2009 Sep;219(1):319-27 - PubMed
  117. Synapse. 2002 Jul;45(1):25-30 - PubMed
  118. Drug Alcohol Depend. 2013 Jan 1;127(1-3):122-8 - PubMed

Publication Types